Please make sure the stock is currently traded on Nasdaq Capital Markets. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Use StemCells to enhance returns of your portfolios. The stock experiences very speculative upward sentiment.. Check odds of StemCells to be traded at $14.4 in 30 days
StemCells Daily Price Distribution
The median price of StemCells for the period between Wed, Nov 9, 2016 and Fri, Dec 9, 2016 is 1.11 with a coefficient of variation of 21.54. The daily time series for the period is distributed with a sample standard deviation of 0.22, arithmetic mean of 1.03, and mean deviation of 0.2. The Stock received some media coverage during the period.
StemCells Inc appears to be very risky and stock price may revert if volatility continues
StemCells Inc has high likelihood to experience some financial distress in the next 2 years
The company currently holds 2 M in liabilities with Debt to Equity (D/E) ratio of 1.6 which is about average as compared to similar companies. StemCells Inc has Current Ratio of 0.6 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.
This company reported previous year revenue of 113.97 K. Net Loss for the year was (20.25 M) with profit before overhead, payroll, taxes, and interest of 116.89 K.
STEMCELLS INC currently holds about 2.08 M in cash with (31.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.13.
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Correlation analysis and pair trading evaluation for StemCells and Amgen Inc. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return